Martin Nicolee, Paterson Beverley J, Durrheim David N
Commun Dis Intell Q Rep. 2014 Jun 30;38(2):E107-13. doi: 10.33321/cdi.2014.38.19.
Australia, like all polio-free countries and regions, remains at risk of a wild poliovirus importation until polio is eradicated globally. The most probable route of importation will be through a traveller arriving in Australia either by air or sea from a polio-endemic or re-infected country. While the overall risk of an imported wild poliovirus infection leading to transmission within Australia is assessed as being low, some areas of the country have been identified as at increased risk. Local areas with relatively high arrivals from polio endemic countries, areas of low vaccination coverage and the potential for transmission to occur when these 2 factors are combined, were identified by this review as Australia's main polio risk. The risk of an importation event leading to locally acquired cases is mitigated by generally high polio vaccination coverage in Australia. This high coverage extends to residents of the Torres Strait Islands who are in close proximity to Papua New Guinea, a country identified as at high risk of poliovirus transmission should an importation occur. In 2012, all states and territories had vaccination coverage of greater than 90% at 1 year of age and all exceeded 93% at 2 years of age. Population immunity to wild poliovirus type 1, which remains the major cause of paralysis globally, has been estimated at 82%. This is sufficient to prevent outbreaks of this type in Australia. Of the 211 eligible non-polio acute flaccid paralysis (AFP) cases classified between 2008 and 2011, 91% (193) were vaccinated against polio at least once. High quality surveillance for AFP, which is supplemented by sentinel enterovirus and environmental surveillance activities, gives confidence that an imported case would be detected and appropriate public health action would ensue.
与所有无脊髓灰质炎的国家和地区一样,在全球消灭脊髓灰质炎之前,澳大利亚仍有输入野生脊髓灰质炎病毒的风险。最有可能的输入途径是乘坐飞机或轮船从脊髓灰质炎流行或重新感染的国家抵达澳大利亚的旅行者。虽然评估认为输入的野生脊髓灰质炎病毒在澳大利亚境内导致传播的总体风险较低,但该国一些地区被确定为风险增加地区。本次审查确定,来自脊髓灰质炎流行国家的抵达人数相对较多的地区、疫苗接种覆盖率较低的地区以及这两个因素结合时可能发生传播的地区,是澳大利亚脊髓灰质炎的主要风险所在。澳大利亚总体较高的脊髓灰质炎疫苗接种覆盖率降低了输入事件导致本地感染病例的风险。这种高覆盖率也适用于托雷斯海峡群岛的居民,该群岛与巴布亚新几内亚相邻,而巴布亚新几内亚被确定为一旦发生输入就有脊髓灰质炎病毒传播高风险的国家。2012年,所有州和领地1岁儿童的疫苗接种覆盖率均超过90%,2岁儿童均超过93%。对全球仍为瘫痪主要病因的1型野生脊髓灰质炎病毒的人群免疫力估计为82%。这足以防止澳大利亚爆发此类疫情。在2008年至2011年分类的211例符合条件的非脊髓灰质炎急性弛缓性麻痹(AFP)病例中,91%(193例)至少接种过一次脊髓灰质炎疫苗。对AFP的高质量监测辅以哨点肠道病毒和环境监测活动,让人相信能够检测到输入病例并采取适当的公共卫生行动。